Jackie
Analyst
Bank of America
Equibles does not estimate personal net worth.
About Jackie
Jackie is recorded as Analyst at Bank of America. Jackie has spoken on 5 earnings calls and 1 other investor event across 4 companies, most recently for Ligand Pharmaceuticals Inc on October 29, 2026. Those appearances were for Ligand Pharmaceuticals Inc (LGND), Syndax Pharmaceuticals Inc (SNDX), Travere Therapeutics, Inc. (TVTX) and Arcus Biosciences, Inc. (RCUS). The companies whose calls Jackie spoke on are classified in the Healthcare sector.
Jackie on recent calls
“So as you look towards 2027, how are you thinking about the pace of capital deployment? And given the growth of the existing portfolio, how much do you need to deploy annually to sustain it?”
“So, you previously characterized the decline in new revenue towards starts as an anomaly. But can you quantify how starts change sequentially within MPM1M and KMT2R?”
“As these programs mature, should we think about them primarily as potential combination partners, competitive threats, or more of an opportunity to expand the market?”
“Appreciating that Seafield is a smaller part of the portfolio, but with the recent label expansion to age one from age eight for the delaying progression to stage three type one diabetes, how does this change your view on the size of the opportunity?”
Affiliation history
-
Bank of America
Analyst
Source not stated
Current